Mild behavioral impairment domains are longitudinally associated with pTAU and metabolic biomarkers in dementia‐free older adults
Alzheimer's & Dementia · 2024-07 · 20 (7) · 4692-4701
DOI: 10.1002/alz.13902 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 14.06.2024. Verfasst von Emmanuel Gonzalez-Bautista und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research and Clinical Alzheimer's Disease Center, CMRR, CHU Toulouse, IHU HealthAge, Toulouse, France. Hauptthemen laut MEDLINE: tau Proteins, Biomarkers, Cognitive Dysfunction. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Gerontologische Pflege, Demenz
Abstract (Originalsprache)
BACKGROUND The mechanisms linking mild behavioral impairment (MBI) and Alzheimer's disease (AD) have been insufficiently explored, with conflicting results regarding tau protein and few data on other metabolic markers. We aimed to evaluate the longitudinal association of the MBI domains and a spectrum of plasma biomarkers. METHODS Our study is a secondary analysis of data from NOLAN. The longitudinal association of the MBI domains with plasma biomarkers, including pTau181, was tested using adjusted linear mixed‐effects models. RESULTS The sample comprised 359 participants (60% female, mean age: 78.3, standard deviation: 0.3 years). After 1 year, the MBI domain of abnormal perception was associated with steeper increases in plasma pTau181. Abnormal perception, decreased motivation, and impulse dyscontrol were associated with homocysteine or insulin dysregulation. DISCUSSION Apart from the association with plasma pTau181, our results suggest that MBI might also represent metabolic dysregulation, probably contributing to dementia transition among older adults with subjective cognitive decline or mild cognitive impairment. Highlights Mild behavioral impairment (MBI) psychosis was associated with steeper increases in plasma p. pTau could be a pharmacological target to treat agitation and psychosis symptoms. MBI domains were linked to metabolic dysregulation involving insulin and homocysteine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research and Clinical Alzheimer's Disease Center, CMRR, CHU Toulouse, IHU HealthAge, Toulouse, France.
- Maintain Aging Research team, CERPOP, Université de Toulouse, Inserm, Université Paul Sabatier, Toulouse, France.
- Departments of Psychiatry, Clinical Neurosciences, Community Health Sciences, and Pathology, Hotchkiss Brain Institute and O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada.
- Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.
ORCID-Profile: Emmanuel Gonzalez-Bautista
Zitieren
APA
Gonzalez-Bautista, E., Momméja, M., de Mauléon, A., Ismail, Z., Vellas, B., Delrieu, J., & Soto Martin, M. E. (2024). Mild behavioral impairment domains are longitudinally associated with pTAU and metabolic biomarkers in dementia‐free older adults. Alzheimer's & Dementia, 20(7), 4692-4701. https://doi.org/10.1002/alz.13902
Vancouver
Gonzalez-Bautista E, Momméja M, de Mauléon A, Ismail Z, Vellas B, Delrieu J, et al. Mild behavioral impairment domains are longitudinally associated with pTAU and metabolic biomarkers in dementia‐free older adults. Alzheimer's & Dementia. 2024;20(7):4692-4701. doi:10.1002/alz.13902
BibTeX
@article{GonzalezBautista2024,
author = {Gonzalez-Bautista, Emmanuel and Momméja, Marie and de Mauléon, Adelaïde and Ismail, Zahinoor and Vellas, Bruno and Delrieu, Julien and Soto Martin, Maria E},
title = {Mild behavioral impairment domains are longitudinally associated with pTAU and metabolic biomarkers in dementia‐free older adults},
journal = {Alzheimer's & Dementia},
year = {2024},
volume = {20},
number = {7},
pages = {4692--4701},
doi = {10.1002/alz.13902}
}
EUVIMED